NASDAQ:ADMA
ADMA Biologics Inc Stock News
$9.10
-0.0600 (-0.655%)
At Close: May 15, 2024
There Is A Lot Of Upside Potential For ADMA Biologics Inc.(NASDAQ: ADMA)
07:00pm, Friday, 19'th Nov 2021 Stocks Register
ADMA Biologics Inc. (NASDAQ:ADMA) price on Friday, November 19, rose 2.73% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.50. A look at the stock’s price movement, the level at last check in today’s session was $1.46, moving within a range at $1.45 and $1.53. The beta … There Is A Lot Of Upside Potential For ADMA Biologics Inc.(NASDAQ: ADMA) Read More »
ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SC
12:00pm, Tuesday, 16'th Nov 2021 GlobeNewswire Inc.
ADMA Now Collects Plasma from Six Vertically Integrated Centers with Three Additional Facilities Under Construction ADMA Now Collects Plasma from Six Vertically Integrated Centers with Three Additiona
ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SC
12:00pm, Tuesday, 16'th Nov 2021 Intrado Digital Media
ADMA Now Collects Plasma from Six Vertically Integrated Centers with Three Additional Facilities Under Construction ADMA Now Collects Plasma from Six Vertically Integrated Centers with Three Additional Facilities Under Construction
ADMA Biologics (NASDAQ:ADMA) Cut to Hold at Zacks Investment Research
09:26pm, Monday, 15'th Nov 2021 Transcript Daily
ADMA Biologics (NASDAQ:ADMA) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research note issued on Monday, Zacks.com reports. According to Zacks, ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious []
ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double
07:49am, Thursday, 11'th Nov 2021
ADMA Biologics Inc (NASDAQ: ADMA) achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million. The increase was favorably impacted by the continued commercial ramp-up of
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call Transcript
08:41pm, Wednesday, 10'th Nov 2021
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call Transcript
Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates
07:05pm, Wednesday, 10'th Nov 2021
Adma Biologics (ADMA) delivered earnings and revenue surprises of 13.33% and 11.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Preview: ADMA Biologics's Earnings
10:58am, Tuesday, 09'th Nov 2021
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement.
ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021
07:00am, Wednesday, 03'rd Nov 2021
Conference Call Scheduled for November 10, 2021 at 4:30 p.m. ET Conference Call Scheduled for November 10, 2021 at 4:30 p.m. ET
ADMA: Insiders Showing Their Cards
06:02pm, Tuesday, 02'nd Nov 2021
ADMA has been trading in a downward trajectory over the past few years. ADMA's stock price has taken a beating from several equity offerings as the business continues to invest in the future.
Best Penny Stocks to Watch as The Market Turns Bullish
09:28am, Friday, 22'nd Oct 2021
Penny stocks are seeing heightened momentum, which companies are you watching? The post Best Penny Stocks to Watch as The Market Turns Bullish appeared first on Penny Stocks to Buy, Picks, News and In
ADMA Stock: Why It Fell Today
08:09am, Thursday, 21'st Oct 2021
The stock price of ADMA Biologics Inc (NASDAQ: ADMA) fell by over 8% pre-market today. This is why it happened.
ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.
07:00am, Monday, 18'th Oct 2021
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 18, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated
ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021
07:00am, Friday, 01'st Oct 2021
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated